Humana Inc. Reports Material Agreement and Financial Obligation

Ticker: HUM · Form: 8-K · Filed: 2025-03-31T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation

TL;DR

Humana signed a new deal and owes money - filing shows March 26th activity.

AI Summary

Humana Inc. filed an 8-K on March 31, 2025, reporting a material definitive agreement and a direct financial obligation. The filing date for the earliest event reported is March 26, 2025. The company is incorporated in Delaware and headquartered in Louisville, Kentucky.

Why It Matters

This filing indicates Humana Inc. has entered into a significant agreement and has incurred a financial obligation, which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — The filing details a material definitive agreement and a financial obligation, which inherently carry risks that could affect the company's financial health.

Key Numbers

Key Players & Entities

FAQ

What type of material definitive agreement did Humana Inc. enter into?

The filing indicates an 'Entry into a Material Definitive Agreement' but does not specify the nature of the agreement in the provided text.

What is the nature of the direct financial obligation or off-balance sheet arrangement?

The filing states 'Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant' but does not provide specific details in the excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on March 26, 2025.

Where are Humana Inc.'s principal executive offices located?

Humana Inc.'s principal executive offices are located at 500 W. Main Street, Louisville, Kentucky 40202.

What is Humana Inc.'s SEC file number?

Humana Inc.'s SEC file number is 001-05975.

From the Filing

0001628280-25-015646.txt : 20250331 0001628280-25-015646.hdr.sgml : 20250331 20250331160633 ACCESSION NUMBER: 0001628280-25-015646 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250326 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250331 DATE AS OF CHANGE: 20250331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 25793205 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20250326.htm 8-K hum-20250326 0000049071 false 0000049071 2025-03-26 2025-03-26 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2025 ( March 26, 2025 ) Humana Inc.   (Exact name of registrant as specified in its charter) Delaware 001-05975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 W. Main Street , Louisville , Kentucky 40202   (Address of principal executive offices, and Zip Code) 502 - 580-1000   Registrant’s telephone number, including area code (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01.     Entry into a Material Definitive Agreement. Underwriting Agreement On March 26, 2025, Humana Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC and Barclays Capital Inc., as representatives of the several underwriters (together, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters an additional $250 million aggregate principal amount of its 5.375% Senior Notes due 2031 (the “Additional 2031 Notes”)

View on Read The Filing